FAP and neoplasm: The dual-targeting PET tracer 68Ga-NOTA-FAPI-RGD, designed to target both FAP and integrin αvβ3, demonstrated significantly enhanced tumor uptake, retention, and TBR compared to its monomeric counterparts 68Ga-FAPI-02 and 68Ga-RGDfK in preclinical pancreatic tumor models [121].